Randomized, Multicentric and Prospective Clinical Trial to Check the Cost-effectiveness of Corifollitropin Alfa vs. Recombinant FSH and/or HP-hMG
Phase of Trial: Phase IV
Latest Information Update: 05 Jul 2017
Price : $35 *
At a glance
- Drugs Corifollitropin alfa (Primary) ; Menotropin; Recombinant follicle-stimulating hormone
- Indications Female infertility
- Focus Therapeutic Use
- 16 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2015 to 1 Dec 2015.
- 16 Jul 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Jun 2015 to 1 Sep 2015.
- 25 Mar 2015 Planned End Date changed from 1 Mar 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.